Skip to content

Zoom Stock Plummets 15% After Coronavirus Vaccine News, At-Home Stocks Tumble

Sam Boughedda
Sam Boughedda trader
Updated 9 Nov 2020

Open Demo Account YOUR CAPITAL IS AT RISK. 68% OF RETAIL CFD ACCOUNTS LOSE MONEY
Zoom HQ

Video conferencing company Zoom Video Communications (NASDAQ: ZM) shares have plunged after news that Pfizer’s coronavirus vaccine is 90% effective. 

new-recommended-broker-banner

Pfizer released the news this morning after analysing data from a large study, representing a possible;e turning point in the fight against the coronavirus pandemic. 

Pfizer and its partner in developing the vaccine, BioNTech are expected to apply for US emergency authorisation later this month. 

The pandemic had been beneficial to Zoom’s share price as companies were forced to adjust to working from home, and Zoom became an essential tool for conducting online meetings. 

ZM

Even now Zoom’s share price is up 515.83% for the year to date, after reaching a high of $588 on October 19th.

However, today’s news has seen it plunge as low as $414.34 per share. It is currently trading at $422.40 after a fall of 15.54%. 

Shares of other at-home companies such as Peloton, Netflix and Slack have also fallen. 

PEOPLE WHO READ THIS ALSO VIEWED:

Sam Boughedda
Sam is a trader and lead stock market writer at AskTraders. After starting his career in the forex market, Sam now focuses on stocks, specifically consumer staples.